page_head_bg

Products

2022 Latest Design Cas No.80681-44-3 - Jujuboside A CAS No. 55466-04-1 – Yongjian

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We continue to keep increasing and perfecting our solutions and service. At the same time, we operate actively to do research and enhancement for Cas No.55290-63-6 , Cas No.41743-73-1 , Cas No.52659-56-0 Kirenol , Winning customers' trust is definitely the gold key to our good results! If you are fascinated in our products, make sure you sense absolutely free to go to our web site or make contact with us.
2022 Latest Design Cas No.80681-44-3 - Jujuboside A CAS No. 55466-04-1 – Yongjian Detail:

Essential Information

Chinese alias: jujube kernel saponin A, jujube kernel saponin A; Jujube kernel saponin A (standard)

English name: Jujuboside A

Plant source: it comes from the seeds of wild jujube, also known as jujube kernel and wild jujube core

Molecular formula: C58H94O26

Molecular weight: 1207.35

CAS No. 55466-04-1

Bioactivity of Jujuboside A

Target: GABA receptor, mTOR, PI3K, Akt [1] [2]

In vitro study: low dose 41 μ Jujuboside A of M (about 0.05 g / L) induced GABA (a) receptors during 24 and 72 h treatment α 1, α 5, β 2 subunit mRNA increased significantly. High dose 82 μ M (about 0.1 g / L) Jujuboside A significantly increased GABA (a) receptors at 24 h α 1, α 5 subunit mRNA levels and decreased β 2 subunit mRNA level and decreased GABA (a) receptor subunit α 1, β 2 mRNA expression was treated at 72 h [1]. Jujuboside A pretreatment can reverse the decrease of cell viability and better induce ISO induced H9c2 cell injury. Jujuboside A can accelerate the phosphorylation of PI3K, Akt and mTOR. Jujuboside A can significantly reduce the proportion of microtubule associated protein LC3-II / I in H9c2 cells [2]

In vivo study: during the day (9:00-15:00), jujubosides significantly increased total sleep and rapid eye movement (REM) sleep, but had no significant effect on non REM (NREM) sleep. At night (21:00-3:00), jujubosides significantly increased total sleep and NREM sleep, especially mild sleep, but had no significant effect on REM sleep and slow wave sleep (SWS) [3]. Intraventricular treatment with jjuboside a was significantly alleviated by a through Y-maze, active avoidance and Morris water maze measurements β 1-42 induced learning and memory impairment in mice. Intracerebroventricular injection of Jujuboside A decreased hippocampal a β 1-42 levels significantly inhibited the activities of acetylcholinesterase (AChE) and no, and decreased the increased content of malondialdehyde (MDA) in hippocampus and cerebral cortex of mice injected into lateral ventricle β 1-42[4]。

Cell experiment: after 7 days of culture in vitro, the cells were continuously exposed for 24 hours or 72 hours, and were not exposed to the medium containing Jujuboside A or diazepam or both. Vector was added to the control group; Diazepam group added 10 μ M diazepam; Jujuboside A82 μ M (about 0.1g / L) and 41 μ M (about 0.05 g / L) was added to jua-h (high dose Jujuboside A) and jua-l (low dose Jujuboside A) groups, respectively. Total RNA was isolated from cells for further analysis [1].

Animal experiment: mice: a was injected through ICV β 1-42 induced cognitive impairment in mice. Then, mice were injected with Jujuboside A (0.02 and 0.2 mg / kg) intraventricular (ICV) for 5 days. Y maze, active avoidance and Morris water maze tests were performed on mice [1].

English Alias of Jujuboside A

α-L-arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1->2)-O-[O-β-D-glucopyranosyl-(1->6)-O-[β-D-xylopyranosyl-(1->2)]-β-D-glucopyranosyl-(1->3)]-

(3β,16β,23R)-20-Hydroxy-16,23:16,30-diepoxydammar-24-en-3-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[β-D-glucopyranosyl-(1->6)-[β-D-xylopyranosyl-(1->2)]-β-D-glucopyranosyl-(1->3)]-α -L-arabinopyranoside

jujuboside C

α-L-Arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1->2)-O-[O-β-D-glucopyranosyl-(1->6)-O-[β-D-xylopyranosyl-(1->2)]- β-D-glucopyranosyl-(1->3)]-

JujubosideA

(3β,16β,23R)-20-Hydroxy-16,23:16,30-diepoxydammar-24-en-3-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[β-D-glucopyranosyl-(1->6)-[β-D-xylopyranosyl-(1->2)]-β-D-glucopyranosyl-(1->3)]-α-L-arabinopyranoside


Product detail pictures:

2022 Latest Design  Cas No.80681-44-3 - Jujuboside A CAS No. 55466-04-1 –  Yongjian detail pictures

2022 Latest Design  Cas No.80681-44-3 - Jujuboside A CAS No. 55466-04-1 –  Yongjian detail pictures


Related Product Guide:

All we do is often involved with our tenet " Purchaser to start with, Rely on initially, devoting over the food stuff packaging and environmental defense for 2022 Latest Design Cas No.80681-44-3 - Jujuboside A CAS No. 55466-04-1 – Yongjian , The product will supply to all over the world, such as: Frankfurt, Adelaide, Honduras, We'd like to invite customers from abroad to discuss business with us. We can present our clients with high quality products and excellent service. We're sure that we'll have good cooperative relationships and make a brilliant future for both parties.
  • The factory workers have rich industry knowledge and operational experience, we learned a lot in working with them,we are extremely grateful that we can encount a good company has excellent wokers.
    5 Stars By Gabrielle from Sao Paulo - 2018.09.23 17:37
    The manufacturer gave us a big discount under the premise of ensuring the quality of products, thank you very much, we will select this company again.
    5 Stars By Lesley from Czech - 2018.11.28 16:25
    Write your message here and send it to us